The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Will The Market Value Of The Nucala Market Change Between 2026 And 2030?
The historical period’s growth is linked to an increasing occurrence of severe eosinophilic asthma, greater awareness of eosinophilic conditions, broader biologic therapy guidelines, more effective diagnostic tests for eosinophil levels, and expanding prescribing habits of specialists.
Expected growth throughout the projection period is driven by the increasing expansion into additional eosinophilic indications, a rising demand for personalized respiratory biologics, ongoing advancements in monoclonal antibody engineering, broader global reimbursement coverage, and increased adoption of home-based administration. Key trends identified for the forecast period include the increasing uptake of targeted biologic asthma therapies, the growing utilization of IL-5 inhibitors in chronic conditions, the expansion of precision medicine approaches within respiratory care, a rising focus on long-term disease control, and enhanced patient stratification practices.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20300&type=smp
Which Significant Factors Are Encouraging Growth In The Nucala Market?
The escalating incidence of asthma is projected to drive the Nucala market’s expansion moving forward. Asthma is a chronic condition affecting the respiratory system, characterized by inflamed and narrowed airways, resulting in symptoms like wheezing, coughing, chest tightness, and shortness of breath, often triggered by allergens or physical activity. The rise in asthma cases is linked to factors such as environmental pollution, allergens, evolving lifestyles, urbanization, and genetic susceptibility. Nucala effectively manages asthma by targeting and inhibiting interleukin-5 (IL-5), a crucial protein involved in the proliferation and activation of eosinophils, which are white blood cells that contribute to airway inflammation in asthma, thus alleviating symptoms and reducing the frequency of exacerbations. For example, in February 2023, as per NHS England, a UK-based government department, in the UK, 5.4 million people receive asthma treatment, with approximately 160,000 new diagnoses annually, and work-related asthma accounts for 9-15% of adult-onset cases. Consequently, the increasing prevalence of asthma is stimulating growth within the Nucala market. The growing frequency of eosinophilic disorders is expected to fuel the Nucala market’s progression. Eosinophilic disorders encompass various medical conditions marked by an excessive production and accumulation of eosinophils, a type of white blood cell, in different tissues, leading to inflammation and potential harm. The rising occurrence of eosinophilic disorders is attributed to elements such as increasing environmental allergens, shifts in dietary patterns, genetic predispositions, and enhanced awareness leading to better diagnostic rates. Nucala (mepolizumab) addresses eosinophilic disorders by specifically targeting and inhibiting interleukin-5 (IL-5), a cytokine essential for the growth and survival of eosinophils, thereby decreasing eosinophil levels and easing associated symptoms. For instance, in December 2023, according to PubMed, a US-based government-operated, non-profit online database, the global pooled incidence and prevalence of EoE were reported as 5.31 cases per 100,000 inhabitant-years. Thus, the increasing prevalence of eosinophilic disorders is propelling growth in the Nucala market.
How Is The Nucala Market Distributed Across Key Segments?
The nucala market covered in this report is segmented –
1) By Indication: Severe Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Chronic Obstructive Pulmonary Disease (COPD), Other Eosinophilic Disorders
2) By Distribution Channel: Direct Sales, Retail Pharmacies, Online Pharmacies
3) By End User: Hospitals, Clinics, Home Care Settings
Which Trends Are Influencing The Expansion Of The Nucala Market?
Major companies operating in the Nucala market are concentrating on developing advanced solutions, such as ready-to-use injectable formulations, to cater to the increasing demand for patient convenience and enhanced treatment adherence. A ready-to-use injectable form refers to a pre-prepared pharmaceutical product that requires no additional dilution or mixing before its administration. For example, in May 2025, GlaxoSmithKline Plc, a UK-based pharmaceutical company, secured approval from the US FDA for Nucala (mepolizumab) for managing adults with chronic obstructive pulmonary disease (COPD) who have an eosinophilic phenotype. This expansion of indication enables targeted therapy for COPD patients with significant unmet needs, a move supported by the encouraging results from the MATINEE and METREX Phase III trials.
Who Are The Key Market Participants In The Nucala Market?
Major companies operating in the nucala market are GlaxoSmithKline plc
Access The Complete Nucala Market Report:
https://www.thebusinessresearchcompany.com/report/nucala-global-market-report
Which Region Contributes The Most To The Nucala Market?
North America was the largest region in the nucala market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucala market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model